Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) stock analysis
In our weekly check, Genomma Lab Internacional, S.A.B. de C.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 5, red flags: 1.
About Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional, S.A.B. de C.V. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Mexico, listed on MEX as LABB.MX.
What our checks show for LABB.MX
Red flags
- The stock has fallen as much as 73% from a peak. Would you have held through that?
Warning signs
- Operating profit covers interest only 3.9 times: a weak year could make the payments hard.
- Revenue grew only 0.6% a year over the last 3 years.
- The net margin is only 10%: little room if costs rise.
- A small company (market value $806 million): usually riskier and followed by fewer analysts.
- The stock is still below its previous peak.
Strengths
- The net margin rose by 1.5 points over 5 years, to 10%.
- Operating cash flow is 1.21x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 15.5% a year over the next years.
- Free cash flow is 11.9% of revenue: cash for dividends, buybacks or growth.
- The dividend takes 46% of profit: there is a cushion.
- The price is 8.9 times earnings (P/E), reasonable for its growth.
Similar companies
HYPE3.SA · IPN.PA · ELAN · VTRS
Questions
What grade does Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) have?
In our weekly check, Genomma Lab Internacional, S.A.B. de C.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 5, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of LABB.MX stock?
This week's biggest flags for Genomma Lab Internacional, S.A.B. de C.V.: Deep past fall, Weak interest cover, Weak revenue growth. In total 6 of 25 checks show a warning or a red flag.
What does Genomma Lab Internacional, S.A.B. de C.V. do?
Genomma Lab Internacional, S.A.B. de C.V. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Mexico, listed on MEX as LABB.MX.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis